So far, that neutral call looks about right. Over the past 12 months, SNPS is basically flat, down about half a percent.

Novo Nordisk A/S launches oral Wegovy in the U.S. with aggressive pricing as China patent expiry looms. Click for this ...

Investors and executives thought electric rentals would print money, turning sleek battery cars into long‑lived assets that ...